Arcutis Biotherapeutics, Inc.
ARQT· Nasdaq
ARQTArcutis Biotherapeutics, Inc.
Filed Aug 5, 2021 · 10-Q · 36 days after period end · 0001787306-21-000008
| Metric | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|
| Net Income | -$42.01M | -$35.41M | -$8.29M |
| EPS Diluted | -$0.84 | -$0.94 | -$4.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcutis Biotherapeutics, Inc. · CIK 1787306 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 5, 2021 · 36 d after period end
